The role of small intestinal bacterial overgrowth in Parkinson's disease.
Identifieur interne : 000891 ( PubMed/Corpus ); précédent : 000890; suivant : 000892The role of small intestinal bacterial overgrowth in Parkinson's disease.
Auteurs : Alfonso Fasano ; Francesco Bove ; Maurizio Gabrielli ; Martina Petracca ; Maria Assunta Zocco ; Enzo Ragazzoni ; Federico Barbaro ; Carla Piano ; Serena Fortuna ; Annalisa Tortora ; Raffaella Di Giacopo ; Mariachiara Campanale ; Giovanni Gigante ; Ernesto Cristiano Lauritano ; Pierluigi Navarra ; Stefano Marconi ; Antonio Gasbarrini ; Anna Rita BentivoglioSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2013.
English descriptors
- KwdEn :
- Aged, Analysis of Variance, Breath Tests, Disease Eradication, Enteritis (complications), Enteritis (epidemiology), Enteritis (prevention & control), Female, Gastric Emptying, Gastrointestinal Motility (physiology), Glucose (metabolism), Helicobacter Infections (complications), Helicobacter Infections (epidemiology), Humans, Intestine, Small (microbiology), Intestine, Small (physiopathology), Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (epidemiology), Parkinson Disease (prevention & control), beta-Galactosidase (metabolism).
- MESH :
- chemical , metabolism : Glucose, beta-Galactosidase.
- complications : Enteritis, Helicobacter Infections, Parkinson Disease.
- epidemiology : Enteritis, Helicobacter Infections, Parkinson Disease.
- microbiology : Intestine, Small.
- physiology : Gastrointestinal Motility.
- physiopathology : Intestine, Small.
- prevention & control : Enteritis, Parkinson Disease.
- Aged, Analysis of Variance, Breath Tests, Disease Eradication, Female, Gastric Emptying, Humans, Male, Middle Aged.
Abstract
Parkinson's disease is associated with gastrointestinal motility abnormalities favoring the occurrence of local infections. The aim of this study was to investigate whether small intestinal bacterial overgrowth contributes to the pathophysiology of motor fluctuations. Thirty-three patients and 30 controls underwent glucose, lactulose, and urea breath tests to detect small intestinal bacterial overgrowth and Helicobacter pylori infection. Patients also underwent ultrasonography to evaluate gastric emptying. The clinical status and plasma concentration of levodopa were assessed after an acute drug challenge with a standard dose of levodopa, and motor complications were assessed by Unified Parkinson's Disease Rating Scale-IV and by 1-week diaries of motor conditions. Patients with small intestinal bacterial overgrowth were treated with rifaximin and were clinically and instrumentally reevaluated 1 and 6 months later. The prevalence of small intestinal bacterial overgrowth was significantly higher in patients than in controls (54.5% vs. 20.0%; P = .01), whereas the prevalence of Helicobacter pylori infection was not (33.3% vs. 26.7%). Compared with patients without any infection, the prevalence of unpredictable fluctuations was significantly higher in patients with both infections (8.3% vs. 87.5%; P = .008). Gastric half-emptying time was significantly longer in patients than in healthy controls but did not differ in patients based on their infective status. Compared with patients without isolated small intestinal bacterial overgrowth, patients with isolated small intestinal bacterial overgrowth had longer off time daily and more episodes of delayed-on and no-on. The eradication of small intestinal bacterial overgrowth resulted in improvement in motor fluctuations without affecting the pharmacokinetics of levodopa. The relapse rate of small intestinal bacterial overgrowth at 6 months was 43%. © 2013 Movement Disorder Society.
DOI: 10.1002/mds.25522
PubMed: 23712625
Links to Exploration step
pubmed:23712625Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of small intestinal bacterial overgrowth in Parkinson's disease.</title><author><name sortKey="Fasano, Alfonso" sort="Fasano, Alfonso" uniqKey="Fasano A" first="Alfonso" last="Fasano">Alfonso Fasano</name><affiliation><nlm:affiliation>Department of Neurology, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy. alfonso.fasano@gmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Bove, Francesco" sort="Bove, Francesco" uniqKey="Bove F" first="Francesco" last="Bove">Francesco Bove</name></author><author><name sortKey="Gabrielli, Maurizio" sort="Gabrielli, Maurizio" uniqKey="Gabrielli M" first="Maurizio" last="Gabrielli">Maurizio Gabrielli</name></author><author><name sortKey="Petracca, Martina" sort="Petracca, Martina" uniqKey="Petracca M" first="Martina" last="Petracca">Martina Petracca</name></author><author><name sortKey="Zocco, Maria Assunta" sort="Zocco, Maria Assunta" uniqKey="Zocco M" first="Maria Assunta" last="Zocco">Maria Assunta Zocco</name></author><author><name sortKey="Ragazzoni, Enzo" sort="Ragazzoni, Enzo" uniqKey="Ragazzoni E" first="Enzo" last="Ragazzoni">Enzo Ragazzoni</name></author><author><name sortKey="Barbaro, Federico" sort="Barbaro, Federico" uniqKey="Barbaro F" first="Federico" last="Barbaro">Federico Barbaro</name></author><author><name sortKey="Piano, Carla" sort="Piano, Carla" uniqKey="Piano C" first="Carla" last="Piano">Carla Piano</name></author><author><name sortKey="Fortuna, Serena" sort="Fortuna, Serena" uniqKey="Fortuna S" first="Serena" last="Fortuna">Serena Fortuna</name></author><author><name sortKey="Tortora, Annalisa" sort="Tortora, Annalisa" uniqKey="Tortora A" first="Annalisa" last="Tortora">Annalisa Tortora</name></author><author><name sortKey="Di Giacopo, Raffaella" sort="Di Giacopo, Raffaella" uniqKey="Di Giacopo R" first="Raffaella" last="Di Giacopo">Raffaella Di Giacopo</name></author><author><name sortKey="Campanale, Mariachiara" sort="Campanale, Mariachiara" uniqKey="Campanale M" first="Mariachiara" last="Campanale">Mariachiara Campanale</name></author><author><name sortKey="Gigante, Giovanni" sort="Gigante, Giovanni" uniqKey="Gigante G" first="Giovanni" last="Gigante">Giovanni Gigante</name></author><author><name sortKey="Lauritano, Ernesto Cristiano" sort="Lauritano, Ernesto Cristiano" uniqKey="Lauritano E" first="Ernesto Cristiano" last="Lauritano">Ernesto Cristiano Lauritano</name></author><author><name sortKey="Navarra, Pierluigi" sort="Navarra, Pierluigi" uniqKey="Navarra P" first="Pierluigi" last="Navarra">Pierluigi Navarra</name></author><author><name sortKey="Marconi, Stefano" sort="Marconi, Stefano" uniqKey="Marconi S" first="Stefano" last="Marconi">Stefano Marconi</name></author><author><name sortKey="Gasbarrini, Antonio" sort="Gasbarrini, Antonio" uniqKey="Gasbarrini A" first="Antonio" last="Gasbarrini">Antonio Gasbarrini</name></author><author><name sortKey="Bentivoglio, Anna Rita" sort="Bentivoglio, Anna Rita" uniqKey="Bentivoglio A" first="Anna Rita" last="Bentivoglio">Anna Rita Bentivoglio</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23712625</idno><idno type="pmid">23712625</idno><idno type="doi">10.1002/mds.25522</idno><idno type="wicri:Area/PubMed/Corpus">000891</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The role of small intestinal bacterial overgrowth in Parkinson's disease.</title><author><name sortKey="Fasano, Alfonso" sort="Fasano, Alfonso" uniqKey="Fasano A" first="Alfonso" last="Fasano">Alfonso Fasano</name><affiliation><nlm:affiliation>Department of Neurology, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy. alfonso.fasano@gmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Bove, Francesco" sort="Bove, Francesco" uniqKey="Bove F" first="Francesco" last="Bove">Francesco Bove</name></author><author><name sortKey="Gabrielli, Maurizio" sort="Gabrielli, Maurizio" uniqKey="Gabrielli M" first="Maurizio" last="Gabrielli">Maurizio Gabrielli</name></author><author><name sortKey="Petracca, Martina" sort="Petracca, Martina" uniqKey="Petracca M" first="Martina" last="Petracca">Martina Petracca</name></author><author><name sortKey="Zocco, Maria Assunta" sort="Zocco, Maria Assunta" uniqKey="Zocco M" first="Maria Assunta" last="Zocco">Maria Assunta Zocco</name></author><author><name sortKey="Ragazzoni, Enzo" sort="Ragazzoni, Enzo" uniqKey="Ragazzoni E" first="Enzo" last="Ragazzoni">Enzo Ragazzoni</name></author><author><name sortKey="Barbaro, Federico" sort="Barbaro, Federico" uniqKey="Barbaro F" first="Federico" last="Barbaro">Federico Barbaro</name></author><author><name sortKey="Piano, Carla" sort="Piano, Carla" uniqKey="Piano C" first="Carla" last="Piano">Carla Piano</name></author><author><name sortKey="Fortuna, Serena" sort="Fortuna, Serena" uniqKey="Fortuna S" first="Serena" last="Fortuna">Serena Fortuna</name></author><author><name sortKey="Tortora, Annalisa" sort="Tortora, Annalisa" uniqKey="Tortora A" first="Annalisa" last="Tortora">Annalisa Tortora</name></author><author><name sortKey="Di Giacopo, Raffaella" sort="Di Giacopo, Raffaella" uniqKey="Di Giacopo R" first="Raffaella" last="Di Giacopo">Raffaella Di Giacopo</name></author><author><name sortKey="Campanale, Mariachiara" sort="Campanale, Mariachiara" uniqKey="Campanale M" first="Mariachiara" last="Campanale">Mariachiara Campanale</name></author><author><name sortKey="Gigante, Giovanni" sort="Gigante, Giovanni" uniqKey="Gigante G" first="Giovanni" last="Gigante">Giovanni Gigante</name></author><author><name sortKey="Lauritano, Ernesto Cristiano" sort="Lauritano, Ernesto Cristiano" uniqKey="Lauritano E" first="Ernesto Cristiano" last="Lauritano">Ernesto Cristiano Lauritano</name></author><author><name sortKey="Navarra, Pierluigi" sort="Navarra, Pierluigi" uniqKey="Navarra P" first="Pierluigi" last="Navarra">Pierluigi Navarra</name></author><author><name sortKey="Marconi, Stefano" sort="Marconi, Stefano" uniqKey="Marconi S" first="Stefano" last="Marconi">Stefano Marconi</name></author><author><name sortKey="Gasbarrini, Antonio" sort="Gasbarrini, Antonio" uniqKey="Gasbarrini A" first="Antonio" last="Gasbarrini">Antonio Gasbarrini</name></author><author><name sortKey="Bentivoglio, Anna Rita" sort="Bentivoglio, Anna Rita" uniqKey="Bentivoglio A" first="Anna Rita" last="Bentivoglio">Anna Rita Bentivoglio</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Analysis of Variance</term><term>Breath Tests</term><term>Disease Eradication</term><term>Enteritis (complications)</term><term>Enteritis (epidemiology)</term><term>Enteritis (prevention & control)</term><term>Female</term><term>Gastric Emptying</term><term>Gastrointestinal Motility (physiology)</term><term>Glucose (metabolism)</term><term>Helicobacter Infections (complications)</term><term>Helicobacter Infections (epidemiology)</term><term>Humans</term><term>Intestine, Small (microbiology)</term><term>Intestine, Small (physiopathology)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson Disease (prevention & control)</term><term>beta-Galactosidase (metabolism)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Glucose</term><term>beta-Galactosidase</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Enteritis</term><term>Helicobacter Infections</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Enteritis</term><term>Helicobacter Infections</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Intestine, Small</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Gastrointestinal Motility</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Intestine, Small</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Enteritis</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Analysis of Variance</term><term>Breath Tests</term><term>Disease Eradication</term><term>Female</term><term>Gastric Emptying</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease is associated with gastrointestinal motility abnormalities favoring the occurrence of local infections. The aim of this study was to investigate whether small intestinal bacterial overgrowth contributes to the pathophysiology of motor fluctuations. Thirty-three patients and 30 controls underwent glucose, lactulose, and urea breath tests to detect small intestinal bacterial overgrowth and Helicobacter pylori infection. Patients also underwent ultrasonography to evaluate gastric emptying. The clinical status and plasma concentration of levodopa were assessed after an acute drug challenge with a standard dose of levodopa, and motor complications were assessed by Unified Parkinson's Disease Rating Scale-IV and by 1-week diaries of motor conditions. Patients with small intestinal bacterial overgrowth were treated with rifaximin and were clinically and instrumentally reevaluated 1 and 6 months later. The prevalence of small intestinal bacterial overgrowth was significantly higher in patients than in controls (54.5% vs. 20.0%; P = .01), whereas the prevalence of Helicobacter pylori infection was not (33.3% vs. 26.7%). Compared with patients without any infection, the prevalence of unpredictable fluctuations was significantly higher in patients with both infections (8.3% vs. 87.5%; P = .008). Gastric half-emptying time was significantly longer in patients than in healthy controls but did not differ in patients based on their infective status. Compared with patients without isolated small intestinal bacterial overgrowth, patients with isolated small intestinal bacterial overgrowth had longer off time daily and more episodes of delayed-on and no-on. The eradication of small intestinal bacterial overgrowth resulted in improvement in motor fluctuations without affecting the pharmacokinetics of levodopa. The relapse rate of small intestinal bacterial overgrowth at 6 months was 43%. © 2013 Movement Disorder Society.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23712625</PMID><DateCreated><Year>2013</Year><Month>09</Month><Day>04</Day></DateCreated><DateCompleted><Year>2014</Year><Month>04</Month><Day>02</Day></DateCompleted><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>9</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>The role of small intestinal bacterial overgrowth in Parkinson's disease.</ArticleTitle><Pagination><MedlinePgn>1241-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25522</ELocationID><Abstract><AbstractText>Parkinson's disease is associated with gastrointestinal motility abnormalities favoring the occurrence of local infections. The aim of this study was to investigate whether small intestinal bacterial overgrowth contributes to the pathophysiology of motor fluctuations. Thirty-three patients and 30 controls underwent glucose, lactulose, and urea breath tests to detect small intestinal bacterial overgrowth and Helicobacter pylori infection. Patients also underwent ultrasonography to evaluate gastric emptying. The clinical status and plasma concentration of levodopa were assessed after an acute drug challenge with a standard dose of levodopa, and motor complications were assessed by Unified Parkinson's Disease Rating Scale-IV and by 1-week diaries of motor conditions. Patients with small intestinal bacterial overgrowth were treated with rifaximin and were clinically and instrumentally reevaluated 1 and 6 months later. The prevalence of small intestinal bacterial overgrowth was significantly higher in patients than in controls (54.5% vs. 20.0%; P = .01), whereas the prevalence of Helicobacter pylori infection was not (33.3% vs. 26.7%). Compared with patients without any infection, the prevalence of unpredictable fluctuations was significantly higher in patients with both infections (8.3% vs. 87.5%; P = .008). Gastric half-emptying time was significantly longer in patients than in healthy controls but did not differ in patients based on their infective status. Compared with patients without isolated small intestinal bacterial overgrowth, patients with isolated small intestinal bacterial overgrowth had longer off time daily and more episodes of delayed-on and no-on. The eradication of small intestinal bacterial overgrowth resulted in improvement in motor fluctuations without affecting the pharmacokinetics of levodopa. The relapse rate of small intestinal bacterial overgrowth at 6 months was 43%. © 2013 Movement Disorder Society.</AbstractText><CopyrightInformation>Copyright © 2013 Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fasano</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy. alfonso.fasano@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Gabrielli</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Petracca</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Zocco</LastName><ForeName>Maria Assunta</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Ragazzoni</LastName><ForeName>Enzo</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Barbaro</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Piano</LastName><ForeName>Carla</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Fortuna</LastName><ForeName>Serena</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tortora</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Di Giacopo</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Campanale</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gigante</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Lauritano</LastName><ForeName>Ernesto Cristiano</ForeName><Initials>EC</Initials></Author><Author ValidYN="Y"><LastName>Navarra</LastName><ForeName>Pierluigi</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Marconi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Gasbarrini</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bentivoglio</LastName><ForeName>Anna Rita</ForeName><Initials>AR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.1.23</RegistryNumber><NameOfSubstance UI="D001616">beta-Galactosidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Mov Disord. 2013 Nov;28(13):1764-5</RefSource><PMID Version="1">24167009</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000704">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001944">Breath Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D060740">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D004751">Enteritis</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000517">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005746">Gastric Emptying</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005769">Gastrointestinal Motility</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005947">Glucose</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016481">Helicobacter Infections</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007421">Intestine, Small</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000517">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001616">beta-Galactosidase</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Helicobacter pylori</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">motor fluctuations</Keyword><Keyword MajorTopicYN="N">small intestinal bacterial overgrowth</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="aheadofprint"><Year>2013</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23712625</ArticleId><ArticleId IdType="doi">10.1002/mds.25522</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000891 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000891 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23712625
|texte= The role of small intestinal bacterial overgrowth in Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23712625" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |